Healthcare DIVE April 19, 2024
The health systems argued in a court filing that regulators’ allegations are based on a “distorted and artificially narrow view” of the healthcare market in the Charlotte area.
Dive Brief:
- Novant Health and Community Health Systems are firing back at regulators’ claims that the proposed $320 million sale of two CHS North Carolina hospitals to Novant would raise prices and reduce incentives to provide quality care.
- In an court filing this week, the health systems argued that the Federal Trade Commission’s allegations are based on a “distorted and artificially narrow view” of the Charlotte, North Carolina-area market that overestimates the hospitals’ competitive power.
- Regulators sued to block the sale of CHS’ Lake Norman Regional Medical Center and Davis Regional...